Vaccine maker got $1 billion from taxpayers. Now it’s boosting drug prices


Unfortunately this is exactly how the present system works.

(From MSN)

AstraZeneca’s second round of increases came after it secured a $1.2-billion commitment in May from the U.S. for vaccine development and as the company was reporting more than $3.6 billion in operating profits in the first half of 2020.

“They clearly made a decision to do their pricing differently, both from their recent past and from their peers, at the same time they were seeking billions of dollars,” said 46brooklyn founder Eric Pachman.

Click here for the article.

This article was originally posted here:

0 0 votes
Article Rating

Follow Against Crony Capitalism on:

Notify of
Inline Feedbacks
View all comments